Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-27

Clinical Trial Update: Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing amodiaquine plus artesunate versus Lapdap plus artesunate for uncomplicated Plasmodium falciparum malaria in Malawi has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amodiaquine (Amodiaquine)
  • Artesunate (artesunate)
  • Lapdap (chlorproguanil-dapsone)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria, Falciparum | Phase 4 | Status: COMPLETED